FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs.
Saved in:
| Title: | FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs. |
|---|---|
| Authors: | Simpson AP; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK., Oldham RJ; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK., Cox KL; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK., Taylor MC; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK., James S; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK., White AL; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK., Bogdanov Y; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK., Glennie MJ; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK., Frendeus B; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; BioInvent International AB, Sölvegatan 41, Lund, Sweden., Cragg MS; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Institute for Life Sciences, University of Southampton, Highfield, Southampton, UK., Roghanian A; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Institute for Life Sciences, University of Southampton, Highfield, Southampton, UK. |
| Source: | Clinical and experimental immunology [Clin Exp Immunol] 2025 Jan 21; Vol. 219 (1). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40089806 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Simpson+AP%22">Simpson AP</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.<br /><searchLink fieldCode="AU" term="%22Oldham+RJ%22">Oldham RJ</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.<br /><searchLink fieldCode="AU" term="%22Cox+KL%22">Cox KL</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.<br /><searchLink fieldCode="AU" term="%22Taylor+MC%22">Taylor MC</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.<br /><searchLink fieldCode="AU" term="%22James+S%22">James S</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.<br /><searchLink fieldCode="AU" term="%22White+AL%22">White AL</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.<br /><searchLink fieldCode="AU" term="%22Bogdanov+Y%22">Bogdanov Y</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.<br /><searchLink fieldCode="AU" term="%22Glennie+MJ%22">Glennie MJ</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.<br /><searchLink fieldCode="AU" term="%22Frendeus+B%22">Frendeus B</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; BioInvent International AB, Sölvegatan 41, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Cragg+MS%22">Cragg MS</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Institute for Life Sciences, University of Southampton, Highfield, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Roghanian+A%22">Roghanian A</searchLink>; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Institute for Life Sciences, University of Southampton, Highfield, Southampton, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220057202%22">Clinical and experimental immunology</searchLink> [Clin Exp Immunol] 2025 Jan 21; Vol. 219 (1). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0057202 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099104%22">00099104 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40089806 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cei/uxaf015 Languages: – Code: eng Text: English Titles: – TitleFull: FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Simpson AP – PersonEntity: Name: NameFull: Oldham RJ – PersonEntity: Name: NameFull: Cox KL – PersonEntity: Name: NameFull: Taylor MC – PersonEntity: Name: NameFull: James S – PersonEntity: Name: NameFull: White AL – PersonEntity: Name: NameFull: Bogdanov Y – PersonEntity: Name: NameFull: Glennie MJ – PersonEntity: Name: NameFull: Frendeus B – PersonEntity: Name: NameFull: Cragg MS – PersonEntity: Name: NameFull: Roghanian A IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 01 Text: 2025 Jan 21 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1365-2249 Numbering: – Type: volume Value: 219 – Type: issue Value: 1 Titles: – TitleFull: Clinical and experimental immunology Type: main |
| ResultId | 1 |
